Navigation Links
Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies
Date:4/29/2008

Lead drug candidate may help patients with Systemic Lupus Erythematosus

(SLE)

SOUTH SAN FRANCISCO, Calif., April 29 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced today that its lead product candidate, R788, has successfully treated lupus prone mice and significantly improved their survival as reported in a recently published study of the drug candidate. R788 (fostamatinib disodium) is an orally bioavailable syk kinase inhibitor, which has shown clinically significant results in treating patients with rheumatoid arthritis and immune thrombocytopenic purpura in clinical trials. A third clinical trial of R788 in patients with B-cell lymphoma will be completed later this year. Rigel also expects to initiate a Phase 2 clinical trial in lupus in the second half of 2008.

The study, which evaluated the potential of R788's effect on the immune cascade in an in vivo lupus model, has been published in Arthritis and Rheumatism and is titled - "An Orally Bioavailable Spleen Tyrosine Kinase Inhibitor Delays Disease Progression and Prolongs Survival in Murine Lupus," (May 2008, Volume 58, No. 5, p.1433).

"These results are impressive and consistent with R788's mechanism of action," said Donald G. Payan, M.D., executive vice president and president of discovery and research at Rigel. "Given this mechanism, R788 has the potential to treat a broad range of immune-related disorders, a number of which we are advancing in the clinic."

Summary of results

The study evaluated the effects of three doses of R788 versus a control group and an untreated group of lupus-prone mice. The mice in the R788 groups orally received 10 mg/kg, 20 mg/kg or 40 mg/kg twice a day
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
2. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
3. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
4. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
5. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
6. Update on Progression of Phosphagenics and Nestle Nutritions Phospha E(R) Trial
7. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
8. Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimers Disease
9. New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
10. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
11. Isis Reports Reduction of apoB-100 Levels in a Murine Model Resulting in Up to 92% Reduction of Atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Dec. 1 WebMD Health Co... information, today announced the honorees of the ... WebMD Health Heroes honor Americans with extraord..., who lead an effort to help others achieve better...m/cgi-bin/prnh/20091201/NY18114 ) ,, "WebMD is...
(Date:12/1/2009)...Dec. 1 CryoLife, Inc. (...nd cardiovascular tissue processing company, annou..., The Company expects total revenues for the full ....0 million, which includes between $1.5 million an...e Department of Defense in connection with the dev...
(Date:12/1/2009)...E, Md., Dec. 1 Sleep Solutions...vider for home testing and evaluation of sleep-dis...chard Hassett, M.D., as its chief executive office...Healthcare, during its growth from a $250 million ...ustry leader in total population health, and its s...
Breaking Medicine Technology:WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Environmentally green beer 3A Munich brewing engineers research energy savings 9825 1Environmentally green beer 3A Munich brewing engineers research energy savings 9825 2Environmentally green beer 3A Munich brewing engineers research energy savings 9825 3Composted dairy manure in foliage plant production 9823 1Composted dairy manure in foliage plant production 9823 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2
... Plan Positions Blue Cross Blue Shield of Mic...rt from HealthLeaders-Inter...terStudy, the,leading provider of managed care mar...inues to stagnate in Michigan, Blue Cross Blue Shi...f its competitors to weather the,economic storm be...
...n,Pharmaceuticals Limited (ASX:PGL; Nasdaq: PGLA) ...nt enrolment in the phase 1 dose-escalation study,...047 (formerly CGC-11047),for patients with advance...-11047 - the lead clinical,compound in the Company...f,Cellgate, Inc earlier this year. The first patie...
Other Medicine Technology:Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2
(Date:12/1/2009)... -- Reportlinker.com announces that a new market r..., Emerging Clinical Trial Locations - India: Mar...atory environment ,, http://www.reportlinker...India-Market-dynamics-and-the-changing-healthcare-...st decade pharmaceutical and biotechnology compani...
(Date:12/1/2009)...ire/ -- As health care reform takes the national s...re delivery model, renowned entrepreneur Henry J. ...Hall of Fame. Kaiser,s eldest granddaughter, Carly...ia medal on his behalf during a formal, private st...iser,s greatest legacy is Kaiser Permanente, one o...
(Date:12/1/2009)...e easily identified, study finds , , TUE...ance imaging test is highly effective at detecting...placenta accreta, researchers report. , The con...s attaches too deeply to a woman,s uterus. During ...terine wall, rupturing blood vessels and putting t...
(Date:12/1/2009)...e-USNewswire/ -- The American Society of Hematolog...ymposium at the New Orleans Marriott on Thursday, ... encourages an interest in hematology, the biologi...junction with the Society,s 51st Annual Meeting. T...plore research on sickle cell disease, an inherite...
(Date:12/1/2009)...re/ -- A national survey reveals the majority of m...s and themselves but at the same time want the rig...milies. ,, See video from HealthyWomen at: htt...of mothers of children aged 12 months and younger ...eding decision prior to going to the hospital to g...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Health News:Reportlinker Adds Emerging Clinical Trial Locations - India: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 2Health News:Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame 3Health News:Serious Pregnancy Complication Detected With MRI 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2
...rs say health professionals and patients require e... the risks associated with over the counter drugs....e of the most common condition that people choose ...n, coughs, colds, and acid stomach. The report ...
...y occurring radioactive gas// without odour, colou...t emanates from the ground into the air. Radon gas...n depending on the highly variable uranium content...lectrically charged and attach to aerosols, dust a...
...ording to the research finding published by the Am...een found that calorie intake may not be a major f...inding was based on a 17-year study of almost 9,79...rticipants were grouped based on reports of calori...
...levels of children exposed to the epilepsy drug in...ere not exposed to the drug.// The study was co...16 who were born to mothers with epilepsy and test...oic acid during pregnancy had an average verbal IQ...
...he next food enlisted in breast cancer prevention,...dy conducted at the University of California. In t...aweed effectively reduced levels of estradiol, // ... good sign when it comes to preventing breast canc...
...ncer – melanoma ,however researchers as the number...s the number of patients surviving the disease. //...ficial influence on some kinds of cancer. In a stu... of sun exposure were less likely to die. Non-H...
Other Medicine News:Health News:WHO Steps Up To Create A Public Awareness About The Consequences Of Exposure To Radon 2
QualCraft™ Gamekeeper Thumb Stabilizer
...tion can be difficult for persons who have suffere...and for children with poor hand control due to cer...s. The FoamWrap ThumDuction Strap positions the th...material provides light control and positioning to...
...amWrap ThumWrap Splints offer support without the ...lieve mild pain or strain due to repetitive stress... rigid or the flexible stay to provide just the ri...e ThumWrap Splint is comfortable to wear even in t...
...s an off-the-shelf wrist orthotic designed to limi...ges-of-motion (20°,35° and 50°). , ,I...ins with TFCC tear-triangular fibrocartilage compl... nonunion , Partial tendon rupture , ORIF - Op...
Medicine Products: